[HTML][HTML] The genomic landscape of endocrine-resistant advanced breast cancers
We integrated the genomic sequencing of 1,918 breast cancers, including 1,501 hormone
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
P Razavi, MT Chang, G Xu, C Bandlamudi… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
We integrated the genomic sequencing of 1,918 breast cancers, including 1,501 hormone
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
[引用][C] The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
P Razavi, MT Chang, G Xu, C Bandlamudi, DS Ross… - Cancer Cell, 2018 - cir.nii.ac.jp
[HTML][HTML] The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
P Razavi, MT Chang, G Xu, C Bandlamudi, DS Ross… - Cancer Cell, 2018 - Elsevier
We integrated the genomic sequencing of 1,918 breast cancers, including 1,501 hormone
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.
P Razavi, MT Chang, G Xu, C Bandlamudi, DS Ross… - Cancer Cell, 2018 - europepmc.org
We integrated the genomic sequencing of 1,918 breast cancers, including 1,501 hormone
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
[HTML][HTML] The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
P Razavi, MT Chang, G Xu, C Bandlamudi, DS Ross… - Cancer cell, 2018 - ncbi.nlm.nih.gov
We integrated the genomic sequencing of 1,918 breast cancers, including 1,501 hormone
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.
P Razavi, MT Chang, G Xu, C Bandlamudi, DS Ross… - Cancer Cell, 2018 - europepmc.org
We integrated the genomic sequencing of 1,918 breast cancers, including 1,501 hormone
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …
receptor-positive tumors, with detailed clinical information and treatment outcomes. In 692 …